HOME >> BIOLOGY >> NEWS
Cornell scientists link E. coli bacteria to Crohn's disease

ITHACA, N.Y. A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague is associated with intestinal inflammation in patients with Crohns disease in their research paper published July 12 by The ISME Journal: Multidisciplinary Journal of Microbial Ecology.

Crohns disease, an incurable inflammatory disorder of the intestine most commonly found in the lower part of the small intestine called the ileum affects 1-in-1,000 people in Europe and North America. Thus far, gut bacteria have long been suspected in playing a pivotal role in the development of Crohns disease, but the specific bacterial characteristics that drive the inflammatory response have remained elusive.

Researchers at Cornell examined possible causes for the disease in patients with Crohns restricted to the ileum and the colon versus healthy individuals.

Given that only about 20 percent of fecal bacteria can be cultured, our group adopted a broad culture-independent approach to target specific subgroups of bacteria for quantitative in situ analysis and culture based characterization, said Kenneth Simpson, professor of small animal medicine at the College of Veterinary Medicine. Our findings raise the possibility that a novel group of E. coli contains opportunistic pathogens that may be causally related to chronic intestinal inflammation in susceptible individuals. They suggest that an integrated approach that considers an individuals mucosa-associated flora in addition to disease phenotype and genotype may improve outcome.

The study found an increased level of E. coli bacteria in more inflamed areas of the small intestines instead of MAP, a bacterium related
'"/>

Contact: Sabina Lee
ssl37@cornell.edu
607-255-3024
Cornell University News Service
7-Aug-2007


Page: 1 2

Related biology news :

1. Weill Cornell team identifies potential new cancer drug target
2. Methodist, University of Houston, Cornell combine biomedical imaging expertise
3. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
4. Cornell lab confirms deadly fish virus spreading to new species
5. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
6. Cornell researchers find serious fish virus in Northeast for first time
7. Cornell finds natural selection in humans
8. Northeast Sun Grant Institute at Cornell spurs green revolution
9. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
10. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader
11. Weill Cornell team develops fast-acting anthrax vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... management solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal ... most inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 ...
(Date:8/1/2018)... ... July 31, 2018 , ... ... Awards at Global Conference , Awards honor late founder of Wisdom National Brands® ... National Brands, presented prestigious stevia awards to a renowned German professor and a ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is now ... The treatments are offered by Double Board Certified providers, with outcomes significantly improving patient ... suppressing symptoms, but have done nothing to help repair and regenerate damaged lung tissues. ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/13/2017)... KING OF PRUSSIA, PA (PRWEB) , ... October 13, 2017 , ... ... Group Vice President and Turesol Business Unit Leader, will moderate a discussion on the ... this year’s ISPE Annual Meeting & Expo . The theme of this year’s ...
Breaking Biology Technology:
Cached News: